186 related articles for article (PubMed ID: 16386050)
1. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity.
Endo A; Kuroda M; Tanzawa K
FEBS Lett; 1976 Dec; 72(2):323-6. PubMed ID: 16386050
[No Abstract] [Full Text] [Related]
2. Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Endo A; Tsujita Y; Kuroda M; Tanzawa K
Eur J Biochem; 1977 Jul; 77(1):31-6. PubMed ID: 908337
[No Abstract] [Full Text] [Related]
3. Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth.
Brown MS; Goldstein JL
J Lipid Res; 1980 Jul; 21(5):505-17. PubMed ID: 6995544
[TBL] [Abstract][Full Text] [Related]
4. RNAi-mediated knockdown of HMG CoA reductase enhances gene expression from physiologically regulated low-density lipoprotein receptor therapeutic vectors in vivo.
Hibbitt O; Agkatsev S; Owen C; Cioroch M; Seymour L; Channon K; Wade-Martins R
Gene Ther; 2012 Apr; 19(4):463-7. PubMed ID: 21796214
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of competitive inhibitors of HMG-CoA reductase.
Corsini A; Maggi FM; Catapano AL
Pharmacol Res; 1995 Jan; 31(1):9-27. PubMed ID: 7784310
[No Abstract] [Full Text] [Related]
6. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
Alberts AW; Chen J; Kuron G; Hunt V; Huff J; Hoffman C; Rothrock J; Lopez M; Joshua H; Harris E; Patchett A; Monaghan R; Currie S; Stapley E; Albers-Schonberg G; Hensens O; Hirshfield J; Hoogsteen K; Liesch J; Springer J
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3957-61. PubMed ID: 6933445
[TBL] [Abstract][Full Text] [Related]
7. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
Lancet; 1994 Nov; 344(8934):1383-9. PubMed ID: 7968073
[TBL] [Abstract][Full Text] [Related]
8. The biological synthesis of cholesterol.
Bloch K
Science; 1965 Oct; 150(3692):19-28. PubMed ID: 5319508
[No Abstract] [Full Text] [Related]
9. Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.
Endo A
J Antibiot (Tokyo); 1979 Aug; 32(8):852-4. PubMed ID: 500505
[No Abstract] [Full Text] [Related]
10. Impact of
Čereškevičius D; Zabiela V; Aldujeli A; Lesauskaitė V; Zubielienė K; Raškevičius V; Čiapienė I; Žaliaduonytė D; Giedraitienė A; Žvikas V; Jakštas V; Skipskis V; Dobilienė O; Šakalytė G; Tatarūnas V
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791422
[TBL] [Abstract][Full Text] [Related]
11. Spinocerebellar Ataxia Type 3 Pathophysiology-Implications for Translational Research and Clinical Studies.
Stahl F; Evert BO; Han X; Breuer P; Wüllner U
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612794
[TBL] [Abstract][Full Text] [Related]
12. From Atheroma to Atherogenic Index, Secular Evidence.
Precoma DB; Rocha GLD
Arq Bras Cardiol; 2024; 120(12):e20230819. PubMed ID: 38451617
[No Abstract] [Full Text] [Related]
13. Conquering cholesterol: a report from the front lines.
Libby P; Pinkosky SL; Nissen SE
Cardiovasc Res; 2023 Dec; 119(17):e160-e163. PubMed ID: 38159295
[No Abstract] [Full Text] [Related]
14. High throughput compound screening in neuronal cells identifies statins as activators of ataxin 3 expression.
Stahl F; Schmitt I; Denner P; de Boni L; Wüllner U; Breuer P
Sci Rep; 2023 Sep; 13(1):14911. PubMed ID: 37689718
[TBL] [Abstract][Full Text] [Related]
15.
Majima H; Arai T; Kamei K; Watanabe A
Microbiol Spectr; 2023 Sep; 11(5):e0266623. PubMed ID: 37655910
[TBL] [Abstract][Full Text] [Related]
16. The pharmacological bases for repurposing statins in depression: a review of mechanistic studies.
De Giorgi R; Rizzo Pesci N; Rosso G; Maina G; Cowen PJ; Harmer CJ
Transl Psychiatry; 2023 Jul; 13(1):253. PubMed ID: 37438361
[TBL] [Abstract][Full Text] [Related]
17. An online experimental medicine trial on the effect of 28-day simvastatin administration on emotional processing, reward learning, working memory and salivary cortisol in healthy volunteers at risk for depression: OxSTEP protocol.
Waters S; De Giorgi R; Quinton AMG; Gillespie AL; Murphy SE; Cowen PJ; Harmer CJ
BJPsych Open; 2023 Jun; 9(4):e110. PubMed ID: 37313755
[TBL] [Abstract][Full Text] [Related]
18. Network Analysis Reveals the Molecular Bases of Statin Pleiotropy That Vary with Genetic Background.
Del Rio Hernandez CE; Campbell LJ; Atkinson PH; Munkacsi AB
Microbiol Spectr; 2023 Mar; 11(2):e0414822. PubMed ID: 36946734
[TBL] [Abstract][Full Text] [Related]
19. Ethnicity based differences in statin use and hypercholesterolemia control among patients with premature coronary artery disease-results of I-PAD study.
Karimi R; Zarepur E; Khosravi A; Mohammadifard N; Nouhi F; Alikhasi H; Nasirian S; Sadeghi M; Roohafza H; Moezi Bady SA; Parisa Janjani ; Solati K; Lotfizadeh M; Ghaffari S; Javanmardi E; Gholipour M; Mostafa Dehghani ; Cheraghi M; Assareh A; Haybar H; Namayandeh SM; Reza Madadi ; Kojuri J; Mansourian M; Sarrafzadegan N
Int J Cardiol Cardiovasc Risk Prev; 2023 Mar; 16():200168. PubMed ID: 36874039
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Utility of PPAR Modulation for Angiogenesis in Cardiovascular Disease.
Wagner N; Wagner KD
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
